NLS Global report

AstraZeneca has entered a new strategic collaboration agreement with CSPC Pharmaceuticals to advance the development of multiple next-generation therapies for obesity and type 2 diabetes across eight programmes.

This investment will expand medicines manufacturing and R&D in China and leverage the country’s scientific excellence, advanced manufacturing, and China-UK healthcare ecosystem collaborations.

The Gates Foundation, Novo Nordisk Foundation, and Wellcome has awarded a new grant funding over the next three years to research teams around the world exploring novel approaches to antibiotic discovery to deal with the growing threat of antimicrobial resistance (AMR).

Women’s health only receives 6% of private healthcare investment despite women representing almost half of the global population, according to a new World Economic Forum report, launched January 20 2026.

In a post on Truth Social, US President Trump said additional 10% import tariffs would take effect on February 1, 2026 on goods from Denmark, Norway, Sweden, France, Germany, the Netherlands, Finland and Great Britain. Those tariffs would increase to 25% on June 1, 2026 and would continue until a deal was reached for the […]

This year's JPM business announces include an oncology deal, obesity and radioligand race positioning, and an AI alliance.